Vyxeos liposomal 44 mg/100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion
7680680140024
CH-68014
Pulver
Associated product:
VYXEOS liposomal subst sèche 44/100 mg 2 pce
1 / 2
google
Article details
- Package size
- 2
- Selling units
- 2
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
44.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Jazz Pharmaceuticals
6300 Zug
Authorization information
- Swissmedic authorization number
- 68014
- Drug name
- Vyxeos liposomal, Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion
- Galenic form
- PULPD
- ATC Code
- L01XY01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 17/02/2022
- Authorization expiration date
- 16/02/2027
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- VYXEOS liposomal subst sèche 44/100 mg 2 pce
- Description (DE)
- VYXEOS liposomal Trockensub 44/100 mg 2 Stk
- Market launch
- 17/02/2022
- Narcotic (BTM)
- No